Fortis Malar Hospitals' Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The auditors issued an unmodified opinion. The company also adopted updated policies for materiality of events and insider trading. Notably, the company confirmed it ceased all business operations after a slump sale in FY24. While evaluating various corporate restructuring options and having no visibility of new operations, management assures sufficient cash of ~Rs 34.58 Cr to meet obligations, including Rs 6.49 Cr for medico-legal cases and tax appeals totaling ~Rs 4.76 Cr, ensuring a going concern basis.